We are live on ! Find out more
MCM

Massar Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+14.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$89.5M
AUM Growth
+$1.53M
Cap. Flow
+$5.1M
Cap. Flow %
5.7%
Top 10 Hldgs %
49.95%
Holding
159
New
112
Increased
–
Reduced
–
Closed
47

Top Buys

Rank Stock Value
1
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$13.3M
2
EWW icon
iShares MSCI Mexico ETF
EWW
+$7.62M
3
MAGS icon
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
+$5.12M
4
INTC icon
Intel
INTC
+$3.28M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$2.65M

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$8.43M
2
ILMN icon
Illumina
ILMN
+$8.02M
3
TKO icon
TKO Group
TKO
+$6.93M
4
UTHR icon
United Therapeutics
UTHR
+$4.63M
5
USFD icon
US Foods
USFD
+$3.88M

Sector Composition

Rank Sector Weight
1 Industrials 10.22%
2 Technology 9.85%
3 Healthcare 8.68%
4 Financials 8.3%
5 Energy 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMSC icon
76
American Superconductor
AMSC
$1.6B
$243K 0.27%
+13,397
New +$334K
CRL icon
77
Charles River Laboratories
CRL
$12.6B
$241K 0.27%
+1,600
New +$268K
SRAD icon
78
Sportradar
SRAD
$3.74B
$238K 0.27%
+11,000
New +$229K
FOA icon
79
Finance of America Companies
FOA
$199M
$234K 0.26%
+11,000
New +$269K
CTSH icon
80
Cognizant
CTSH
$25.1B
$233K 0.26%
+3,049
New +$248K
LBRT icon
81
Liberty Energy
LBRT
$3.17B
$219K 0.25%
+13,845
New +$249K
ARQT icon
82
Arcutis Biotherapeutics
ARQT
$3.39B
$219K 0.24%
+14,000
New +$197K
ESOA icon
83
Energy Services of America
ESOA
$286M
$214K 0.24%
+22,656
New +$247K
PCRX icon
84
Pacira BioSciences
PCRX
$979M
$211K 0.24%
+8,500
New +$203K
HQY icon
85
HealthEquity
HQY
$8.73B
$208K 0.23%
+2,359
New +$242K
Z icon
86
Zillow
Z
$8.26B
$206K 0.23%
+3,001
New +$229K
CERT icon
87
Certara
CERT
$1.25B
$195K 0.22%
+19,733
New +$240K
PCT icon
88
PureCycle Technologies
PCT
$1.38B
$173K 0.19%
+25,000
New +$225K
WVE icon
89
Wave Life Sciences
WVE
$1.17B
$173K 0.19%
+21,356
New +$234K
GDRX icon
90
GoodRx Holdings
GDRX
$1.11B
$166K 0.19%
+37,668
New +$177K
ANGI icon
91
Angi Inc
ANGI
$194M
$159K 0.18%
+10,347
New +$176K
DFTX
92
Definium Therapeutics
DFTX
$5.89B
$144K 0.16%
+24,583
New +$176K
TOI icon
93
The Oncology Institute
TOI
$513M
$114K 0.13%
+100,000
New +$77.4K
NGL icon
94
NGL Energy Partners
NGL
$2.12B
$104K 0.12%
+22,848
New +$114K
DH icon
95
Definitive Healthcare
DH
$70.4M
$101K 0.11%
+35,000
New +$142K
ICAD
96
DELISTED
iCAD Inc
ICAD
$101K 0.11%
+48,915
New +$124K
NVTS icon
97
Navitas Semiconductor
NVTS
$3.22B
$94.8K 0.11%
+46,242
New +$133K
ARAY icon
98
Accuray
ARAY
$32.8M
$86.8K 0.1%
+48,469
New +$101K
PSNL icon
99
Personalis
PSNL
$1.44B
$84.1K 0.09%
+23,973
New +$114K
HCAT icon
100
Health Catalyst
HCAT
$177M
$84K 0.09%
+18,545
New +$98.1K
2 3
4
5 6

Similar funds

NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
FPI
Financial Plan Inc Bellingham, Washington $933M AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
GP
Greenline Partners New York $930M AUM 29.59% 1-Year Est. Return

Massar Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Massar Capital Management held 159 positions worth $89.5M, up 1.7% from $87.9M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Massar Capital Management deployed $5.1M of net new capital in Q1 2025, opening 112 new positions. Its largest new stake was iShares MSCI Brazil ETF: 535,000 shares worth $13.8M.

By sector, the portfolio is most concentrated in Industrials at 10% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the most notable exit was Moderna, an estimated $8.43M sold.

  • Massar Capital Management's largest Q1 2025 buy was iShares MSCI Brazil ETF: 535,000 shares worth $13.8M.
  • Massar Capital Management fully exited Moderna in Q1 2025, selling an estimated $8.43M.
  • Massar Capital Management's ten largest holdings make up 50% of its $89.5M portfolio in Q1 2025.
  • Massar Capital Management opened 112 new positions and closed 47 in Q1 2025.
  • Massar Capital Management's portfolio value rose 1.7% quarter-over-quarter to $89.5M.

Based on Massar Capital Management's 13F filing for Q1 2025, filed 15 May 2025.